Securities code: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) securities abbreviation: Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) Announcement No.: 2022023 bond Code: 113585 bond abbreviation: Shouxian convertible bond
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896)
It has not been approved by the securities regulatory authorities and stock exchanges in the past five years
Announcement of taking regulatory measures or punishment
The board of directors and all directors of the company guarantee that there are no false records, misleading statements or major omissions in the contents of this announcement, and bear individual and joint liabilities for the authenticity, accuracy and completeness of its contents.
Whereas Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) (hereinafter referred to as “the company”) intends to apply to the China Securities Regulatory Commission for public issuance of convertible corporate bonds, the company has conducted a self-examination on whether it has been taken regulatory measures or penalties by the China Securities Regulatory Commission and its dispatched offices and Shanghai Stock Exchange in the past five years. The self-examination results are as follows:
In strict accordance with the relevant provisions and requirements of the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the Listing Rules of Shanghai Stock Exchange and the Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) articles of association, the company has continuously improved the corporate governance structure, established and improved the internal management and control system, improved the standard operation level of the company, actively protected the legitimate rights and interests of investors and promoted the sustainable, stable and healthy development of the company. Through self inspection, the company has not been subject to regulatory measures or penalties taken by China Securities Regulatory Commission and its dispatched offices and Shanghai Stock Exchange in the past five years.
It is hereby announced.
Zhejiang Shouxiangu Pharmaceutical Co.Ltd(603896) board of directors April 1, 2022
